GASTROINTESTINAL STROMAL TUMOUR CANCER

Motion Text

That this House supports the aims of GIST Support UK, the key charity specifically focused on combating gastrointestinal stromal tumour (GIST); acknowledges that GIST is a rare and awful form of cancer commonly found in the digestive system; and calls on the Government to ensure that the only effective third-line drug that treats GIST, the Stivarga form of the drug Regorafenib, remains accessible to patients in England as it is in Scotland to ensure English patients are not second-class citizens.